9th International Eye and Vision Congress

Gene Therapy in Ophthalmology

Gene therapy in ophthalmology is propelling transformative advancements, offering hope for treating inherited eye diseases. This personalized precision approach, facilitated by emerging viral vector technologies, holds promise in restoring vision for those affected by conditions like Leber congenital amaurosis (LCA), retinitis pigmentosa, and choroideremia. Clinical successes underscore its potential, as patients have shown remarkable improvements, perceiving light, shapes, and even reading letters on an eye chart post-treatment.

Collaborative efforts among geneticists, ophthalmologists, and researchers fuel the field's progress. While challenges persist, such as refining vector delivery and ensuring affordability, gene therapy's trajectory promises a future where untreatable eye conditions can be managed or even cured through gene-based interventions.